Cardiac Effects of Fixed-dose Dual Bronchodilator in Patients With Heart Insufficiency and COPD
Phase of Trial: Phase IV
Latest Information Update: 15 Aug 2016
At a glance
- Drugs Glycopyrrolate/indacaterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms CREATES
- 08 Aug 2016 Status changed from not yet recruiting to recruiting.
- 04 Aug 2016 Planned End Date changed from 1 Jul 2018 to 1 Aug 2018.
- 04 Aug 2016 Planned primary completion date changed from 1 Jul 2018 to 1 Aug 2017.